PPI-amoxicillin for H. Pylori Treatment

Summary

This randomized controlled clinical trial will identify the additional benefit of bismuth or metronidazole in proton pump inhibitor-amoxicillin-containing therapy for Helicobacter pylori first-line treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.

Timeline

Start

2021-08-20

Primary completion

2022-12-30

Completion

2022-12-30

Drugs

Indications